Cargando…
Mimicking microbial strategies for the design of mucus-permeating nanoparticles for oral immunization
Dealing with mucosal delivery systems means dealing with mucus. The name mucosa comes from mucus, a dense fluid enriched in glycoproteins, such as mucin, which main function is to protect the delicate mucosal epithelium. Mucus provides a barrier against physiological chemical and physical aggressors...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7126451/ https://www.ncbi.nlm.nih.gov/pubmed/25615880 http://dx.doi.org/10.1016/j.ejpb.2015.01.010 |
_version_ | 1783516148879327232 |
---|---|
author | Gamazo, Carlos Martín-Arbella, Nekane Brotons, Ana Camacho, Ana I. Irache, J.M. |
author_facet | Gamazo, Carlos Martín-Arbella, Nekane Brotons, Ana Camacho, Ana I. Irache, J.M. |
author_sort | Gamazo, Carlos |
collection | PubMed |
description | Dealing with mucosal delivery systems means dealing with mucus. The name mucosa comes from mucus, a dense fluid enriched in glycoproteins, such as mucin, which main function is to protect the delicate mucosal epithelium. Mucus provides a barrier against physiological chemical and physical aggressors (i.e., host secreted digestive products such as bile acids and enzymes, food particles) but also against the potentially noxious microbiota and their products. Intestinal mucosa covers 400 m(2) in the human host, and, as a consequence, is the major portal of entry of the majority of known pathogens. But, in turn, some microorganisms have evolved many different approaches to circumvent this barrier, a direct consequence of natural co-evolution. The understanding of these mechanisms (known as virulence factors) used to interact and/or disrupt mucosal barriers should instruct us to a rational design of nanoparticulate delivery systems intended for oral vaccination and immunotherapy. This review deals with this mimetic approach to obtain nanocarriers capable to reach the epithelial cells after oral delivery and, in parallel, induce strong and long-lasting immune and protective responses. |
format | Online Article Text |
id | pubmed-7126451 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Elsevier B.V. |
record_format | MEDLINE/PubMed |
spelling | pubmed-71264512020-04-08 Mimicking microbial strategies for the design of mucus-permeating nanoparticles for oral immunization Gamazo, Carlos Martín-Arbella, Nekane Brotons, Ana Camacho, Ana I. Irache, J.M. Eur J Pharm Biopharm Article Dealing with mucosal delivery systems means dealing with mucus. The name mucosa comes from mucus, a dense fluid enriched in glycoproteins, such as mucin, which main function is to protect the delicate mucosal epithelium. Mucus provides a barrier against physiological chemical and physical aggressors (i.e., host secreted digestive products such as bile acids and enzymes, food particles) but also against the potentially noxious microbiota and their products. Intestinal mucosa covers 400 m(2) in the human host, and, as a consequence, is the major portal of entry of the majority of known pathogens. But, in turn, some microorganisms have evolved many different approaches to circumvent this barrier, a direct consequence of natural co-evolution. The understanding of these mechanisms (known as virulence factors) used to interact and/or disrupt mucosal barriers should instruct us to a rational design of nanoparticulate delivery systems intended for oral vaccination and immunotherapy. This review deals with this mimetic approach to obtain nanocarriers capable to reach the epithelial cells after oral delivery and, in parallel, induce strong and long-lasting immune and protective responses. Elsevier B.V. 2015-10 2015-01-20 /pmc/articles/PMC7126451/ /pubmed/25615880 http://dx.doi.org/10.1016/j.ejpb.2015.01.010 Text en Copyright © 2015 Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Gamazo, Carlos Martín-Arbella, Nekane Brotons, Ana Camacho, Ana I. Irache, J.M. Mimicking microbial strategies for the design of mucus-permeating nanoparticles for oral immunization |
title | Mimicking microbial strategies for the design of mucus-permeating nanoparticles for oral immunization |
title_full | Mimicking microbial strategies for the design of mucus-permeating nanoparticles for oral immunization |
title_fullStr | Mimicking microbial strategies for the design of mucus-permeating nanoparticles for oral immunization |
title_full_unstemmed | Mimicking microbial strategies for the design of mucus-permeating nanoparticles for oral immunization |
title_short | Mimicking microbial strategies for the design of mucus-permeating nanoparticles for oral immunization |
title_sort | mimicking microbial strategies for the design of mucus-permeating nanoparticles for oral immunization |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7126451/ https://www.ncbi.nlm.nih.gov/pubmed/25615880 http://dx.doi.org/10.1016/j.ejpb.2015.01.010 |
work_keys_str_mv | AT gamazocarlos mimickingmicrobialstrategiesforthedesignofmucuspermeatingnanoparticlesfororalimmunization AT martinarbellanekane mimickingmicrobialstrategiesforthedesignofmucuspermeatingnanoparticlesfororalimmunization AT brotonsana mimickingmicrobialstrategiesforthedesignofmucuspermeatingnanoparticlesfororalimmunization AT camachoanai mimickingmicrobialstrategiesforthedesignofmucuspermeatingnanoparticlesfororalimmunization AT irachejm mimickingmicrobialstrategiesforthedesignofmucuspermeatingnanoparticlesfororalimmunization |